Screen could offer better safety tests for new chemicals
Using specialized liver cells, a new test can quickly detect potentially cancer-causing DNA damage.
Using specialized liver cells, a new test can quickly detect potentially cancer-causing DNA damage.
Long-lasting capsule can remain in the stomach and release contraceptive drugs over several weeks.
MIT researchers identify pyrimidine biosynthesis as a target for the treatment of small cell lung cancer.
His technology platforms have benefited genomics, diagnostics, and drug screening.
Senior Kristy Carpenter aims to leverage artificial intelligence and other computational tools to develop new, more affordable drugs.
System could help with diagnosing and treating noncommunicative patients.
New system could free bench chemists from time-consuming tasks, may help inspire new molecules.
Researchers hope the system can zero in on the right patients to enroll in clinical trials, to speed discovery of drug treatments.
Whitehead Institute team finds drugs that activate a key brain gene; initial tests in cells and mice show promise for rare, untreatable neurodevelopmental disorder.
Researchers from MIT's Koch Institute will work with teams in the UK and Europe to use nanoparticles to carry multiple drug therapies to treat glioblastoma.
Compound that knocks out a DNA repair pathway enhances cisplatin treatment and helps prevent drug-resistance.
Algorithm stitches multiple datasets into a single “panorama,” which could provide new insights for medical and biological studies.
Data-sampling method makes “sketches” of unwieldy biological datasets while still capturing the full diversity of cell types.
The substance that bathes tumors in the body is quite different from the medium used to grow cancer cells in the lab, biologists report.
Technique could improve machine-learning tasks in protein design, drug testing, and other applications.